Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11017)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cohen JG, White M, Cruz A, Farias-Eisner R. In 2014, can we do better than CA125 in the early detection of ovarian cancer? World J Biol Chem 2014; 5(3): 286-300 [PMID: 25225597 DOI: 10.4331/wjbc.v5.i3.286] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v5/i3/286.htm |
| Number | Citing Articles |
| 1 |
Amelie Fassbender, Dorien O, Christian M. Becker, Thomas D’Hooghe. Biomarkers for Endometriosis. 2017; : 123 doi: 10.1007/978-3-319-59856-7_7
|
| 2 |
Olusegun Kayode Ajenifuja, Kunle Odunsi. Contemporary Obstetrics and Gynecology for Developing Countries. 2021; : 633 doi: 10.1007/978-3-030-75385-6_58
|
| 3 |
Meenal Rastogi, Sameer Gupta, Manisha Sachan. Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects. Brazilian Archives of Biology and Technology 2016; 59(0) doi: 10.1590/1678-4324-2016160070
|
| 4 |
JUN ZHOU, GUANGHUI GONG, HONG TAN, FURONG DAI, XIN ZHU, YILE CHEN, JUNPU WANG, YING LIU, PUXIANG CHEN, XIAOYING WU, JIFANG WEN. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. Oncology Reports 2015; 33(6): 2915 doi: 10.3892/or.2015.3937
|
| 5 |
Dandan Yuan, Yilei Zhao, Yang Wang, Jianhua Che, Wenhua Tan, Yuxia Jin, Fei Wang, Peiliang Li, Shuyan Fu, Qian Liu, Wenliang Zhu. Effect of integrin-linked kinase gene silencing on microRNA expression in ovarian cancer. Molecular Medicine Reports 2017; 16(5): 7267 doi: 10.3892/mmr.2017.7523
|
| 6 |
Han-Wei Lin, Ying-Cheng Chiang, Nai-Yun Sun, Yu-Li Chen, Chi-Fang Chang, Yi-Jou Tai, Chi-An Chen, Wen-Fang Cheng. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells. Endocrine-Related Cancer 2019; 26(1): 73 doi: 10.1530/ERC-18-0300
|
| 7 |
Xiaoqin Liu, Yunzhao Xu, Qin Jin, Wei Wang, Shu Zhang, Xudong Wang, Yuquan Zhang, Xujuan Xu, Jianfei Huang. EphA8 is a prognostic marker for epithelial ovarian cancer. Oncotarget 2016; 7(15): 20801 doi: 10.18632/oncotarget.8018
|
| 8 |
Augusti Mary Priyanka, Shubhada Suhas Jajoo. RISK OF MALIGNANCY INDEX IN PREOPERATIVE EVALUATION OF ADNEXAL MASSES. Journal of Evolution of Medical and Dental Sciences 2018; 7(50): 5352 doi: 10.14260/jemds/2018/1185
|
| 9 |
Changwon Yang, Hee Seung Kim, Gwonhwa Song, Whasun Lim. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches. Journal of Cellular Physiology 2019; 234(12): 21493 doi: 10.1002/jcp.28905
|
| 10 |
Kazim Sahin, Engin Yenice, Mehmet Tuzcu, Cemal Orhan, Cengizhan Mizrak, Ibrahim H. Ozercan, Nurhan Sahin, Bahiddin Yilmaz, Birdal Bilir, Bulent Ozpolat, Omer Kucuk. Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens. Journal of Cancer Prevention 2018; 23(1): 25 doi: 10.15430/JCP.2018.23.1.25
|
| 11 |
Ahmed H. Al-Salem, Munther J. Haddad, Moustafa Hamchou. Pediatric Gynecology. 2020; : 317 doi: 10.1007/978-3-030-49984-6_17
|
| 12 |
Hanan Babeker, Jessica Pougoue Ketchemen, Arunkumar Annan Sudarsan, Samitha Andrahennadi, Anjong Florence Tikum, Anand Krishnan Nambisan, Humphrey Fonge, Maruti Uppalapati. Engineering of a Fully Human Anti-MUC-16 Antibody and Evaluation as a PET Imaging Agent. Pharmaceutics 2022; 14(12): 2824 doi: 10.3390/pharmaceutics14122824
|
| 13 |
Miguel Ángel Elorriaga, José Luis Neyro, Jon Mieza, Ignacio Cristóbal, Antoni Llueca. Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature. Journal of Personalized Medicine 2021; 11(11): 1115 doi: 10.3390/jpm11111115
|
| 14 |
Rudolf Kaaks, Renée Turzanski Fortner, Anika Hüsing, Myrto Barrdahl, Marika Hopper, Theron Johnson, Anne Tjønneland, Louise Hansen, Kim Overvad, Agnès Fournier, Marie‐Christine Boutron‐Ruault, Marina Kvaskoff, Laure Dossus, Mattias Johansson, Heiner Boeing, Antonia Trichopoulou, Vassiliki Benetou, Carlo La Vecchia, Sabina Sieri, Amalia Mattiello, Domenico Palli, Rosario Tumino, Giuseppe Matullo, N. Charlotte Onland‐Moret, Inger T. Gram, Elisabete Weiderpass, Maria‐Jose Sánchez, Carmen Navarro Sanchez, Eric J. Duell, Eva Ardanaz, Nerea Larranaga, Eva Lundin, Annika Idahl, Karin Jirström, Björn Nodin, Ruth C. Travis, Elio Riboli, Melissa Merritt, Dagfinn Aune, Kathryn Terry, Daniel W. Cramer, Karen S. Anderson. Tumor‐associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation. International Journal of Cancer 2018; 143(3): 515 doi: 10.1002/ijc.31335
|
| 15 |
Shin-Wha Lee, Ha-Young Lee, Hyo Joo Bang, Hye-Jeong Song, Sek Won Kong, Yong-Man Kim. An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy. International Journal of Molecular Sciences 2019; 20(19): 4938 doi: 10.3390/ijms20194938
|
| 16 |
Ying Zhang, Wei Hua, Li-chun Niu, Shi-mei Li, Ying-mei Wang, Lei Shang, Cun Zhang, Wei-na Li, Rui Wang, Bi-liang Chen, Xiao-yan Xin, Ying-qi Zhang, Jian Wang. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients. Tumor Biology 2016; 37(7): 9423 doi: 10.1007/s13277-015-4699-x
|
| 17 |
Yi-Chao Lee, Chi-Chen Huang, Ding-Yen Lin, Wen-Chang Chang, Kuen-Haur Lee. Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance. PeerJ 2015; 3: e1386 doi: 10.7717/peerj.1386
|
| 18 |
Yan Liu, Hui Zhang, Xiaoqian Li, Guiqin Qi. Combined Application of Ultrasound and CT Increased Diagnostic Value in Female Patients with Pelvic Masses. Computational and Mathematical Methods in Medicine 2016; 2016: 1 doi: 10.1155/2016/6146901
|
| 19 |
Trasias Mukama, Renée Turzanski Fortner, Verena Katzke, Lucas Cory Hynes, Agnese Petrera, Stefanie M. Hauck, Theron Johnson, Matthias Schulze, Catarina Schiborn, Agnetha Linn Rostgaard-Hansen, Anne Tjønneland, Kim Overvad, María José Sánchez Pérez, Marta Crous-Bou, María-Dolores Chirlaque, Pilar Amiano, Eva Ardanaz, Eleanor L. Watts, Ruth C. Travis, Carlotta Sacerdote, Sara Grioni, Giovanna Masala, Simona Signoriello, Rosario Tumino, Inger T. Gram, Torkjel M. Sandanger, Hanna Sartor, Eva Lundin, Annika Idahl, Alicia K. Heath, Laure Dossus, Elisabete Weiderpass, Rudolf Kaaks. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. British Journal of Cancer 2022; 126(9): 1301 doi: 10.1038/s41416-021-01697-z
|
| 20 |
Yanjun Qu, Yanan He, Zhangming Li, Xiuwei Chen, Qian Liu, Shuangshuang Zou, Congcong Kong, Yixiu Liu, Ce Gao, Guangmei Zhang, Wenliang Zhu. Constructing an ovarian cancer metastasis index by dissecting medical records. Oncotarget 2017; 8(60): 102212 doi: 10.18632/oncotarget.22336
|
| 21 |
Camille V. Trinidad, Ashley L. Tetlow, Leonidas E. Bantis, Andrew K. Godwin. Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers. Cancer Prevention Research 2020; 13(3): 241 doi: 10.1158/1940-6207.CAPR-19-0184
|
| 22 |
Ying Wu, Hongling Peng, Xia Zhao. Diagnostic Performance of Contrast-Enhanced Ultrasound for Ovarian Cancer: A Meta-Analysis. Ultrasound in Medicine & Biology 2015; 41(4): 967 doi: 10.1016/j.ultrasmedbio.2014.11.018
|
| 23 |
Jingjing Deng, Ming Zhang, Hualiang Zhang, Chao Lu, Guoxin Hou, Yan Feng, Zhixian Fang, Xiaodong Lv. Value of Growth/Differentiation Factor 15 in Diagnosis and the Evaluation of Chemotherapeutic Response in Lung Cancer. Clinical Therapeutics 2021; 43(4): 747 doi: 10.1016/j.clinthera.2021.02.001
|
| 24 |
Mohamed A. Elzek, Karin D. Rodland. Proteomics of ovarian cancer: functional insights and clinical applications. Cancer and Metastasis Reviews 2015; 34(1): 83 doi: 10.1007/s10555-014-9547-8
|
| 25 |
S Ramadoss, S Sen, I Ramachandran, S Roy, G Chaudhuri, R Farias-Eisner. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance. Oncogene 2017; 36(11): 1537 doi: 10.1038/onc.2016.320
|
| 26 |
Robert L. Coleman, Jinsong Liu, Koji Matsuo, Premal H. Thaker, Shannon N. Westin, Anil K. Sood. Abeloff's Clinical Oncology. 2020; : 1525 doi: 10.1016/B978-0-323-47674-4.00086-4
|
| 27 |
Vivek Kumar, Sameer Gupta, Kachnar Varma, Amrita Chaurasia, Manisha Sachan. Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction. Journal of Gynecologic Oncology 2022; 33(4) doi: 10.3802/jgo.2022.33.e49
|
| 28 |
Jian Cao, Huan Wang, Jing Yang, Jing Zhang, Dake Li, Pengfei Xu. Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer. Cell Division 2023; 18(1) doi: 10.1186/s13008-023-00099-2
|
| 29 |
Stavros Diavatis, Alexis Papanikolaou. Level of HE4 is Correlated with Diagnosis of Struma Ovarii: A Case Report. American Journal of Case Reports 2016; 17: 459 doi: 10.12659/AJCR.897158
|
| 30 |
Ilaria Lamberti, Simona Scarano, Carla Lucia Esposito, Antonio Antoccia, Giovanni Antonini, Caterina Tanzarella, Vittorio De Franciscis, Maria Minunni. In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing. Methods 2016; 97: 58 doi: 10.1016/j.ymeth.2015.10.022
|
| 31 |
S. C. Faria, T. Sagebiel, M. Patnana, V. Cox, C. Viswanathan, C. Lall, A. Qayyum, P. R. Bhosale. Tumor markers: myths and facts unfolded. Abdominal Radiology 2019; 44(4): 1575 doi: 10.1007/s00261-018-1845-0
|
| 32 |
Vasco D. B. Bonifácio. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1219: 355 doi: 10.1007/978-3-030-34025-4_18
|
| 33 |
Etsuko Miyagi, Yasuyo Maruyama, Tae Mogami, Reiko Numazaki, Atsuko Ikeda, Hiroshi Yamamoto, Fumiki Hirahara. Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors. International Journal of Clinical Oncology 2017; 22(1): 118 doi: 10.1007/s10147-016-1035-4
|
| 34 |
Mona Alharbi, Andrew Lai, Shayna Sharma, Priyakshi Kalita-de Croft, Nihar Godbole, America Campos, Dominic Guanzon, Alexis Salas-Burgos, Flavio Carrion, Felipe A. Zuñiga, Lewis Perrin, Yaowu He, Tanja Pejovic, Carmen Winters, Terry Morgan, John D. Hooper, Gregory E. Rice, Carlos Salomon. Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence. Cancers 2021; 13(14): 3388 doi: 10.3390/cancers13143388
|
| 35 |
Gordon Greville, Amanda McCann, Pauline M. Rudd, Radka Saldova. Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics 2016; 11(12): 845 doi: 10.1080/15592294.2016.1241932
|
| 36 |
Gregory Benedetto, Timothy J. Hamp, Peter J. Wesselman, Christine Richardson. Identification of Epithelial Ovarian Tumor-Specific Aptamers. Nucleic Acid Therapeutics 2015; 25(3): 162 doi: 10.1089/nat.2014.0522
|
| 37 |
Xin Zhang, Junling Liu, Dan Zang, Shu Wu, Aibin Liu, Jinrong Zhu, Geyan Wu, Jun Li, Lili Jiang. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression. Oncotarget 2015; 6(17): 15180 doi: 10.18632/oncotarget.3737
|
| 38 |
Bin Zheng, Li Geng, Li Zeng, Fangfang Liu, Qiaojia Huang. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis. Cellular Signalling 2018; 45: 122 doi: 10.1016/j.cellsig.2018.01.021
|
| 39 |
Jerry Z Yao, Igor F Tsigelny, Santosh Kesari, Valentina L Kouznetsova. Diagnostics of ovarian cancer via metabolite analysis and machine learning. Integrative Biology 2023; 15 doi: 10.1093/intbio/zyad005
|
| 40 |
MS Khalaf. Comparison between Haptoglobin and CA125 to Predict Nature of Ovarian Mass. Women's Health 2016; 3(2) doi: 10.15406/mojwh.2016.03.00065
|
| 41 |
Katrina K Au, Juliana A Josahkian, Julie-Ann Francis, Jeremy A Squire, Madhuri Koti. Current State of Biomarkers in Ovarian Cancer Prognosis. Future Oncology 2015; 11(23): 3187 doi: 10.2217/fon.15.251
|
| 42 |
Vinícius Pereira de Carvalho, Mariana Lopes Grassi, Camila de Souza Palma, Helio Humberto Angotti Carrara, Vitor Marcel Faça, Francisco José Candido dos Reis, Aline Poersch. The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers. Translational Research 2019; 206: 71 doi: 10.1016/j.trsl.2018.11.001
|
| 43 |
ZHIPING HE, ALLEN Y. CHEN, YON ROJANASAKUL, GARY O. RANKIN, YI CHARLIE CHEN. Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells. Oncology Reports 2016; 35(1): 291 doi: 10.3892/or.2015.4354
|
| 44 |
Raluca Eftimie, Esraa Hassanein. Improving cancer detection through combinations of cancer and immune biomarkers: a modelling approach. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1432-8
|
| 45 |
Nabil Abdalla, Robert Piorkowski, Michal Bachanek, Pawel Stanirowski, Krzysztof Cendrowski, Wlodzimierz Sawicki. Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/5289804
|
| 46 |
Langanani Mbodi, Precious Mathebela, Zodwa Dlamini. Artificial Intelligence and Precision Oncology. 2023; : 139 doi: 10.1007/978-3-031-21506-3_7
|
| 47 |
Nurhijriyah Kam Siregar, Agus Kartono, Tony Sumaryada. Numerical method of the cancer dynamics model with cancer biomarker (CA-125) or immune (IL-7) for early detection. INTERNATIONAL CONFERENCE ON SCIENCE AND APPLIED SCIENCE (ICSAS) 2021 2022; 2391: 030004 doi: 10.1063/5.0073718
|
| 48 |
Srinidhi Cherukuri, Shubhada Jajoo, Deepika Dewani. The International Ovarian Tumor Analysis-Assessment of Different Neoplasias in the Adnexa (IOTA-ADNEX) Model Assessment for Risk of Ovarian Malignancy in Adnexal Masses. Cureus 2022; doi: 10.7759/cureus.31194
|
| 49 |
YOUNG-AH SUH, SE-YOUNG JO, HWA-YOUNG LEE, CHUHEE LEE. Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells. International Journal of Oncology 2015; 46(3): 1405 doi: 10.3892/ijo.2014.2808
|
| 50 |
Tatiana Pochechueva, Alexander Chinarev, Andreas Schoetzau, André Fedier, Nicolai V. Bovin, Neville F. Hacker, Francis Jacob, Viola Heinzelmann-Schwarz, Pierre Busson. Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients. PLOS ONE 2016; 11(10): e0164230 doi: 10.1371/journal.pone.0164230
|